D. R. Cary
发表
Masahiro Ito,
S. Aparicio,
T. Kawamoto,
2020,
Biochemical and biophysical research communications.
S. Barlow,
D. O′Hare,
Jennifer C. Green,
2000
.
S. Barlow,
D. O′Hare,
Jennifer C. Green,
1997
.
K. Fukuda,
Y. Imaeda,
Y. Kosugi,
2017,
ACS medicinal chemistry letters.
Masahiro Ito,
S. Aparicio,
T. Kawamoto,
2017,
Journal of medicinal chemistry.
Maki Hasegawa,
Kazunobu Aoyama,
A. Hata,
2017,
Bioorganic & medicinal chemistry.
Hiroshi Banno,
Yuka Hasegawa,
M. Okaniwa,
2017,
Bioorganic & medicinal chemistry.
D. O′Hare,
Mark J. Drewitt,
D. R. Cary,
1998
.
K. Masuya,
Yutaka Kobayashi,
N. Nishizawa,
2020,
Organic letters.
J. Arnold,
D. R. Cary,
1994
.
Jian Sun,
D. M. Penny,
Wanli Lu,
2009,
Biochemistry.
G. Ball,
J. Arnold,
D. R. Cary,
1995
.
J. Arnold,
D. R. Cary,
1993
.
J. Satcher,
S. Lane,
W. P. van Antwerp,
2002,
Inorganic chemistry.
D. O′Hare,
S. Shyu,
A. Fogg,
1998
.
K. Saikatendu,
C. Arrowsmith,
M. Schapira,
2018,
Oncotarget.
M. Tawada,
Naoki Miyamoto,
Yuya Oguro,
2013,
Bioorganic & medicinal chemistry.
Yoshikazu Ohta,
Tomoyasu Ishikawa,
Terufumi Takagi,
2013,
ACS medicinal chemistry letters.
Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding Mode.
M. Klein,
R. Tjhen,
Biching Sang,
2019,
ACS medicinal chemistry letters.
K. Masuya,
P. Reid,
D. R. Cary,
2017
.
K. Masuya,
M. Yoshino,
D. R. Cary,
2021,
Organic Process Research & Development.
Masataka Fumoto,
Shiho Yamamoto,
Shota Uehara,
2021,
ACS medicinal chemistry letters.